Acute myelogenous leukemia (AML) is a cancer of the blood and bone marrow — the spongy tissue inside bones where blood cells are made.
The word "acute" in acute myelogenous leukemia denotes the disease's rapid progression. It's called myelogenous (my-uh-LOHJ-uh-nus) leukemia because it affects a group of white blood cells called the myeloid cells, which normally develop into the various types of mature blood cells, such as red blood cells, white blood cells and platelets.
Acute myelogenous leukemia is also known as acute myeloid leukemia, acute myeloblastic leukemia, acute granulocytic leukemia and acute nonlymphocytic leukemia.
AML care at Mayo Clinic
General signs and symptoms of the early stages of acute myelogenous leukemia may mimic those of the flu or other common diseases. Signs and symptoms may vary based on the type of blood cell affected.
Signs and symptoms of acute myelogenous leukemia include:
- Bone pain
- Lethargy and fatigue
- Shortness of breath
- Pale skin
- Frequent infections
- Easy bruising
- Unusual bleeding, such as frequent nosebleeds and bleeding from the gums
When to see a doctor
Make an appointment with a doctor if you develop any signs or symptoms that seem unusual or that worry you.
Acute myelogenous leukemia is caused by damage to the DNA of developing cells in your bone marrow. When this happens, blood cell production goes wrong. The bone marrow produces immature cells that develop into leukemic white blood cells called myeloblasts. These abnormal cells are unable to function properly, and they can build up and crowd out healthy cells.
In most cases, it's not clear what causes the DNA mutations that lead to leukemia. Radiation, exposure to certain chemicals and some chemotherapy drugs are known risk factors for acute myelogenous leukemia.
Factors that may increase your risk of acute myelogenous leukemia include:
- Increasing age. The risk of acute myelogenous leukemia increases with age. Acute myelogenous leukemia is most common in adults age 65 and older.
- Your sex. Men are more likely to develop acute myelogenous leukemia than are women.
- Previous cancer treatment. People who've had certain types of chemotherapy and radiation therapy may have a greater risk of developing AML.
- Exposure to radiation. People exposed to very high levels of radiation, such as survivors of a nuclear reactor accident, have an increased risk of developing AML.
- Dangerous chemical exposure. Exposure to certain chemicals, such as benzene, is linked to a greater risk of AML.
- Smoking. AML is linked to cigarette smoke, which contains benzene and other known cancer-causing chemicals.
- Other blood disorders. People who've had another blood disorder, such as myelodysplasia, myelofibrosis, polycythemia vera or thrombocythemia, are at greater risk of developing AML.
- Genetic disorders. Certain genetic disorders, such as Down syndrome, are associated with an increased risk of AML.
Many people with AML have no known risk factors, and many people who have risk factors never develop the cancer.
Acute myelogenous leukemia care at Mayo Clinic
Dec. 27, 2017
- Niederhuber JE, et al., eds. Acute leukemias in adults. In: Abeloff's Clinical Oncology. 5th ed. Philadelphia, Pa.: Churchill Livingstone Elsevier; 2014. https://www.clinicalkey.com. Accessed June 4, 2017.
- Hoffman R, et al. Clinical manifestations and treatment of acute myelogenous leukemia. In: Hematology: Basic Principles and Practice. 6th ed. Philadelphia, Pa.: Saunders Elsevier; 2013. https://www.clinicalkey.com. Accessed June 4, 2017.
- Adult acute myeloid leukemia treatment (PDQ). National Cancer Institute. https://www.cancer.gov/types/leukemia/patient/adult-aml-treatment-pdq. Accessed June 4, 2017.
- Leukemia — acute myeloid — AML. Cancer.Net. http://www.cancer.net/cancer-types/leukemia-acute-myeloid-aml/view-all. Accessed June 4, 2017.
- Integrative medicine and complementary and alternative therapies. Leukemia & Lymphoma Society. https://www.lls.org/treatment/integrative-medicine-and-complementary-and-alternative-therapies. Accessed June 4, 2017.
- Riggin ER. Allscripts EPSi. Mayo Clinic, Rochester, Minn. July 5, 2017.
- Rydapt (prescribing information). East Hanover, N.J.: Novartis Pharmaceuticals Corp.; 2017. https://www.us.rydapt.com/. Accessed June 4, 2017.
- Acute myeloid leukemia. Fort Washington, Pa.: National Comprehensive Cancer Network. http://www.nccn.org/professionals/physician_gls/f_guidelines.asp. Accessed March 31, 2017.
- Kaushansky K, et al., eds. Acute myelogenous leukemia. In: Williams Hematology. 9th ed. New York, N.Y.: McGraw-Hill Education; 2016. http://www.accessmedicine.mhmedical.com. Accessed March 31, 2017.
- AskMayoExpert. Acute myeloid leukemia. Rochester, Minn.: Mayo Foundation for Medical Education and Research; 2015.
- Begna KH (expert opinion). Mayo Clinic, Rochester, Minn. Aug. 9, 2017.
Acute myelogenous leukemia